- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03956927
Feasibility of Simulation in Therapeutic Patient Education for Adult Diabetic Patients Using the Freestyle Libre® Device (PRE-SIMPA)
The benefits of Therapeutic Patient Education (TPE) have long been proven, but its implementation remains insufficient. It is only accessible to a part of the population and is too often limited to the acquisition of knowledge. TPE consists of supporting the patient in making decisions about his or her health, managing his or her life with the disease and treatment through the acquisition or maintenance of skills.
Simulation is a pedagogical method of creating fictional or reconstructed environments in order to develop skills, know-how and abilities for which direct instruction is impossible for ethical, economic or technical reasons. To date, it is recommended for the development of caregiver skills, and has been the subject of two studies among family caregivers. It seems likely that simulation will add value to the methods currently used in TPE.
To our knowledge, no studies have been conducted on simulation-based TPE (S-TPE) with patients.
A consensus conference, which is a rigorous method of comparing the opinions of experts in TPE, simulation, patient experts and caregivers, was held in order to determine the learning that could be developed through simulation and the conditions of use. However, since the patient is a specific type of learner, we hypothesize that there may be some additional conditions for the use of S-TPE. And the value of this approach remains to be demonstrated. Since the use of S-TPE has never been studied with patients, a feasibility test would make it possible to evaluate, in the context of care, the possibility of its use and its acceptance by both patients and caregivers. This is necessary before considering a multicenter trial that demonstrates an interest in developing patient skills. It was decided to carry out this study in patients with diabetes, a condition for which TPE is a precursor. Caregivers will be able to objectify the advantages and limitations of using S-TPE.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Dijon, France, 21000
- Chu Dijon Bourgogne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult who has provided non-opposition to participate in the study
- Insulin-dependent diabetic patient who has participated in a complete TPE program (3 sessions) for the implementation of a FreeStyle Libre®.
Exclusion Criteria:
- Person subject to a legal protection measure (curatorship, guardianship)
- Person subject to limited judicial protection
- Pregnant, parturient or breastfeeding woman
- Adulat patients unable to provide consent
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
patients
Insulin-dependent diabetic patients who have participated in a full TPE program (3 sessions)
|
S-TPE stimulation session with groups of 8 patients.
The simulation is performed by a single patient, the others are observers in a neighbouring room where the scene is projected.
Pre- and post-simulation administration of self-efficacy and anxiety questionnaires (IASTA Y1 and Y2)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
level of perceived utility of the S-TPE
Time Frame: Through study completion, an average of 9 months
|
The level of perceived utility of S-TPE for patients and caregivers through self-administered Likert scale questionnaires
|
Through study completion, an average of 9 months
|
Patient satisfaction: Likert scale
Time Frame: Through study completion, an average of 9 months
|
The degree of patient satisfaction at the end of the simulation sequence by self-administered questionnaire with a Likert scale
|
Through study completion, an average of 9 months
|
Organizational advantages and limitations
Time Frame: Through study completion, an average of 9 months
|
Organizational, human, material, material and temporal facilities and limitations for patients and caregivers by analyzing the verbatim of the T0 questionnaires and interviewing them at T1
|
Through study completion, an average of 9 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PENNECOT 2019
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin-Dependent Diabetes
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
National Nutrition and Food Technology InstituteCompletedNon Insulin Dependent DiabetesIran, Islamic Republic of
-
Lille Catholic UniversityUniversity Hospital, LilleTerminatedNon-insulin-dependent DiabetesFrance
-
National Nutrition and Food Technology InstituteUnknownNon Insulin Dependent DiabetesIran, Islamic Republic of
-
VeraLight, Inc.CompletedDiabetes Mellitus, Non-Insulin DependentUnited States
-
National Center for Complementary and Integrative...CompletedDiabetes Mellitus, Non-Insulin Dependent | Non-Insulin DependentUnited States
-
Procter and GambleTerminatedNon-Insulin-dependent Diabetes MellitusUnited States
-
Inha University HospitalCompletedNon Insulin Dependent Diabetes MellitusKorea, Republic of
-
Samsung Medical CenterMinistry of Trade, Industry & Energy, Republic of Korea; Korea Evaluation Institute... and other collaboratorsCompletedDiabetes Mellitus | Insulin-dependent Diabetes Mellitus | Insulin HypoglycemiaKorea, Republic of
-
VeraLight, Inc.CompletedDiabetes Mellitus, Non-Insulin DependentUnited States
Clinical Trials on S-TPE
-
Hannover Medical SchoolCompleted
-
Rennes University HospitalCompleted
-
Alexandria UniversityCompleted
-
Fenwal, Inc.CompletedAutoimmune Diseases | Oncologic Disorders | Renal Disorders | Hematologic DisordersUnited States
-
Fresenius Medical Care Deutschland GmbHX-act Cologne Clinical Research GmbHNot yet recruiting
-
Emory UniversityCompleted
-
Neurological Associates of West Los AngelesEnrolling by invitation
-
Taipei City HospitalTaipei Medical University Shuang Ho HospitalCompletedBreast Cancer | Radiotherapy | Chinese Herbal MedicineTaiwan
-
University of RostockUnknown
-
University Hospital, MontpellierNot yet recruiting